Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reprogramming cells for transplantation.

Jonathan Leor1, Alexander Battler, Robert A Kloner

  • 1Neufeld Cardiac Research Institute, Sheba Medical Center, Tel-Hashomer, Israel. leorj@post.tau.ac.il

Heart Failure Reviews
|July 25, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Insights Into Heart-Tumor Interactions in Heart Failure.

Circulation research·2025
Same author

Atherosclerotic Cardiovascular Diseases Are Associated With Incident Metastatic and Nonmetastatic Cancer.

JACC. CardioOncology·2025
Same author

Response by Caller et al to Letter Regarding Article, "Small Extracellular Vesicles From Infarcted and Failing Heart Accelerate Tumor Growth".

Circulation·2024
Same author

Small Extracellular Vesicles From Infarcted and Failing Heart Accelerate Tumor Growth.

Circulation·2024
Same author

CRISPR-Cas9 editing of TLR4 to improve the outcome of cardiac cell therapy.

Scientific reports·2023
Same author

Osteopontin promotes infarct repair.

Basic research in cardiology·2022
Same journal

Overcoming barriers to early diagnosis and treatment of p.Val142Ile amyloid transthyretin (ATTR) cardiomyopathy.

Heart failure reviews·2026
Same journal

Beyond vasodilation: sotatercept and the remodeling hypothesis in hfpef-associated pulmonary hypertension.

Heart failure reviews·2026
Same journal

Beyond the right ventricle: left heart involvement in pulmonary arterial hypertension.

Heart failure reviews·2026
Same journal

Left ventricular non-compaction in heart failure: contemporary perspective on diagnostic challenges and treatment opportunities.

Heart failure reviews·2026
Same journal

Correction to: Left atrial shunting devices: why, what, how, and… when?

Heart failure reviews·2026
Same journal

Cardiac microcurrent therapy in heart failure: Mechanistic rationale, early clinical evidence, and future directions.

Heart failure reviews·2026
See all related articles

Tissue engineering offers a promising approach to repair heart damage by reprogramming cells. This strategy involves genetically modifying a patient

Area of Science:

  • Regenerative Medicine
  • Cardiovascular Biology
  • Biotechnology

Background:

  • Myocardial damage, particularly in elderly patients, presents a significant clinical challenge.
  • Existing treatments for heart failure often have limitations, especially when myogenic or angiogenic cells are depleted.
  • Cellular reprogramming and rejuvenation are emerging fields with potential for cardiac repair.

Purpose of the Study:

  • To review and present data supporting the potential of tissue engineering for myocardial repair.
  • To highlight a combined genetic and tissue engineering strategy for cardiac regeneration.
  • To explore the clinical relevance of this approach for specific patient populations.

Main Methods:

  • Review of existing scientific literature and data on stem cell reprogramming and cell rejuvenation.

Related Experiment Videos

  • Analysis of strategies for ex vivo cell expansion and genetic engineering.
  • Evaluation of cell reintroduction techniques for creating replacement cardiac tissue.

    • Main Results:

    • Data supports the feasibility of using engineered cells for myocardial repair.
    • Genetic engineering can enhance the properties of cells for improved cardiac function.
    • The proposed strategy shows potential for preventing left ventricular (LV) deterioration.

    Conclusions:

    • Combined genetic and tissue engineering represents a promising strategy for treating myocardial damage.
    • This approach could be particularly beneficial for elderly patients and those with depleted cell reserves.
    • Further development may lead to effective treatments for preventing heart failure.